The relative levels of oxysterols and the status of menopause can be important for the adjustment of dosing regimen of doxorubicin in the neoadjuvant and adjuvant chemotherapy of breast cancer patients with a high ratio of ERα/ERβ. This evidence concerns the gene ESR1 and breast cancer.